Ictero Medical Overview

  • Year Founded
  • 2018

Year Founded

  • Status
  • Private

  • Employees
  • 4

Employees

  • Latest Deal Type
  • Series AA

  • Latest Deal Amount
  • $344K

  • Investors
  • 9

Ictero Medical General Information

Description

Developer of an invasive gallbladder ablation tool designed to treat high-risk patients with gallstone disease. The company's treatment can be used in the interventional radiology suite with only minimal local anesthesia to defunctionalize the gallbladder without having to remove it, enabling physicians to give their patients the benefits of surgery without the risk.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 114 Holmes Road
  • Suite 203
  • Houston, TX 77045
  • United States
+1 (713)
Primary Industry
Diagnostic Equipment
Other Industries
Other Devices and Supplies
Vertical(s)
Corporate Office
  • 114 Holmes Road
  • Suite 203
  • Houston, TX 77045
  • United States
+1 (713)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Ictero Medical Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
9. Later Stage VC (Series AA) 05-Nov-2026 $344K Completed Generating Revenue
8. Secondary Transaction - Private Completed Generating Revenue
7. Early Stage VC (Series A) 28-Apr-2022 Completed Generating Revenue
6. Grant 23-Dec-2019 Completed Generating Revenue
5. Accelerator/Incubator Completed Generating Revenue
4. Grant 28-May-2019 Completed Generating Revenue
3. Accelerator/Incubator 01-Mar-2019 Completed Generating Revenue
2. Accelerator/Incubator 21-Oct-2018 $25K $25K Completed Generating Revenue
1. Accelerator/Incubator 01-Jun-2018 Completed Generating Revenue
To view Ictero Medical’s complete valuation and funding history, request access »

Ictero Medical Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series AA
Series A-2
Series A-1 4,276,877 $0.000010 $1.4 $1.4 1x $1.4 5.22%
To view Ictero Medical’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Ictero Medical Patents

Ictero Medical Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026015858-A1 Systems, devices, and methods for ablation and defunctionalization of gallbladder with delivery of low freezing point agent Pending 11-Jul-2024
US-20260151174-A1 Systems, devices, and methods for ablation and defunctionalization of a gallbladder Pending 06-Jan-2023
WO-2024148351-A1 Systems, devices, and methods for ablation and defunctionalization of a gallbladder Inactive 06-Jan-2023
US-20250221754-A1 Systems, devices, and methods for ablation and defunctionalization of a gallbladder with dosage feedback Pending 10-Feb-2022
WO-2023154886-A1 Systems, devices, and methods for ablation and defunctionalization of a gallbladder with dosage feedback Inactive 10-Feb-2022 A61B18/0218
To view Ictero Medical’s complete patent history, request access »

Ictero Medical Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Ictero Medical Investors (9)

Investor Name Investor Type Holding Investor Since Participating Rounds
MedTex Ventures Venture Capital Minority
S3 Ventures Venture Capital Minority
Texas Halo Fund Venture Capital Minority
Texas A&M New Ventures Competition University Minority
US National Science Foundation Accelerator/Incubator
You’re viewing 5 of 9 investors. Get the full list »

Ictero Medical FAQs

  • When was Ictero Medical founded?

    Ictero Medical was founded in 2018.

  • Where is Ictero Medical headquartered?

    Ictero Medical is headquartered in Houston, TX.

  • What is the size of Ictero Medical?

    Ictero Medical has 4 total employees.

  • What industry is Ictero Medical in?

    Ictero Medical’s primary industry is Diagnostic Equipment.

  • Is Ictero Medical a private or public company?

    Ictero Medical is a Private company.

  • What is the current valuation of Ictero Medical?

    The current valuation of Ictero Medical is .

  • What is Ictero Medical’s current revenue?

    The current revenue for Ictero Medical is .

  • How much funding has Ictero Medical raised over time?

    Ictero Medical has raised $7.52M.

  • Who are Ictero Medical’s investors?

    MedTex Ventures, S3 Ventures, Texas Halo Fund, Texas A&M New Ventures Competition, and US National Science Foundation are 5 of 9 investors who have invested in Ictero Medical.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process